Cytosorbents Corp Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Cytosorbents Corp quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Cytosorbents Corp Other Assets, Noncurrent for the quarter ending September 30, 2024 was $3.8M, a 8.38% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.8M -$348K -8.38% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $3.77M -$504K -11.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.92M -$526K -11.8% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $3.96M -$479K -10.8% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $4.15M -$547K -11.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.28M -$392K -8.39% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $4.45M -$239K -5.11% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $4.44M -$521K -10.5% Dec 31, 2022 10-K 2024-03-15
Q3 2022 $4.7M -$170K -3.49% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $4.67M -$117K -2.44% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $4.68M +$169K +3.75% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $4.96M +$610K +14% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $4.87M +$595K +13.9% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $4.79M +$660K +16% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $4.52M +$782K +21% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $4.35M +$863K +24.8% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $4.27M +$1.02M +31.6% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $4.13M +$1.05M +34% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $3.73M +$822K +28.3% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $3.48M +$732K +26.6% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $3.24M +$623K +23.8% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $3.08M +$684K +28.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $2.91M +$731K +33.5% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $2.75M +$792K +40.4% Dec 31, 2018 10-K 2020-03-05
Q3 2018 $2.62M +$823K +45.7% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $2.4M +$776K +47.9% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $2.18M +$760K +53.5% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $1.96M +$665K +51.3% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $1.8M +$619K +52.4% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.62M +$583K +56.2% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $1.42M +$518K +57.5% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $1.3M +$459K +54.9% Dec 31, 2016 10-K 2018-03-08
Q3 2016 $1.18M +$449K +61.5% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.04M +$382K +58.4% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $902K +$249K +38.2% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $837K +$221K +35.9% Dec 31, 2015 10-K 2017-03-03
Q3 2015 $731K +$250K +52% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $655K +$193K +41.6% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $652K +$243K +59.2% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $616K +$201K +48.6% Dec 31, 2014 10-K 2016-03-09
Q3 2014 $481K +$230K +91.3% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $463K +$211K +84% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $410K +$152K +59.1% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $414K +$160K +63% Dec 31, 2013 10-K 2015-03-31
Q3 2013 $251K -$27.1K -9.72% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 $251K -$35.8K -12.5% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $258K -$19.9K -7.16% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $254K -$15.8K -5.84% Dec 31, 2012 10-K 2014-03-31
Q3 2012 $278K +$4.63K +1.69% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 $287K +$16K +5.9% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 $277K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $270K +$2.42K +0.9% Dec 31, 2011 10-K 2013-04-03
Q3 2011 $274K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $271K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $268K Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.